Todd Tillemans, a global business leader with 30 years of experience in personal care, beauty, food and beverage, is the new CEO of Cynosure, LLC. Tillemans is the former president of Hershey's flagship U.S. business generating over $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever’s skin and personal care portfolio where he helped build global personal care brands, including Dove, Axe, Vaseline, Ponds and Degree. Tillemans succeeds Erik Anderson who joined Cynosure from Hologic in 2017 as vice president of sales and led the organization as president for the past six months under Hologic’s ownership prior to Cynosure’s acquisition by funds managed by Clayton, Dubilier & Rice (CD&R).
“Todd is an inspiring executive with demonstrated success building diverse and talented executive teams and motivating them to achieve transformational success,” said Sandi Peterson, chairman of Cynosure and operating partner at CD&R. “He understands that sustainable growth is the product of sound strategic vision, innovative consumer insight and a passion for executional excellence.”
“It’s a privilege to be joining Cynosure where the growth opportunities are so significant and supported by many powerful macro tailwinds, including broader interest in treatment options across demographics, technological enhancements that allow for safe, effective noninvasive procedures, and a larger pool of healthcare professionals and medical spas offering aesthetic medical services,” said Tillemans. “I look forward to collaborating with the entire Cynosure global team to leverage their past success as well as invest in new capabilities and technologies to further accelerate the delivery of best-in-class innovation.”
In other leadership developments, Cynosure announced that Jorge Pinedo, former senior vice president at Johnson & Johnson, will join the company as executive vice president, international, to lead the company’s growth initiatives across global geographies. Pinedo most recently led Johnson & Johnson’s $600 million Vision Care business in Asia-Pacific. He previously held senior roles at Hasbro, Mead Johnson Nutrition and Bristol-Myers,.
